User profiles for Vinay Prasad
 | Vinay Prasad, MD MPHProfessor, University of California San Francisco Verified email at ucsf.edu Cited by 13565 |
[HTML][HTML] Perspective: the precision-oncology illusion
V Prasad - Nature, 2016 - nature.com
… Vinay Prasad … Precision oncology has not been shown to work, and perhaps it never
will, says Vinay Prasad. … Vinay Prasad …
will, says Vinay Prasad. … Vinay Prasad …
A decade of reversal: an analysis of 146 contradicted medical practices
… Author links open overlay panel Vinay Prasad MD a , Andrae Vandross MD b , Caitlin …
The views and opinions of Dr Prasad do not necessarily reflect those of the National Cancer …
The views and opinions of Dr Prasad do not necessarily reflect those of the National Cancer …
Five years of cancer drug approvals: innovation, efficacy, and costs
S Mailankody, V Prasad - JAMA oncology, 2015 - jamanetwork.com
… Mailankody S, Prasad V. Five Years of Cancer Drug Approvals: Innovation, Efficacy, and
Costs. JAMA Oncol. … Sham Mailankody, MB BS 1 ; Vinay Prasad, MD, MPH 1 …
Costs. JAMA Oncol. … Sham Mailankody, MB BS 1 ; Vinay Prasad, MD, MPH 1 …
Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs
Importance Immunotherapy checkpoint inhibitors have generated considerable interest
because of durable responses in a number of hitherto intractable tumor types. Objective To …
because of durable responses in a number of hitherto intractable tumor types. Objective To …
The strength of association between surrogate end points and survival in oncology: a systematic review of trial-level meta-analyses
Importance The strength of association between surrogate end points and survival in oncology
is important to understand because surrogate end points are frequently used in oncology …
is important to understand because surrogate end points are frequently used in oncology …
Reversals of established medical practices: evidence to abandon ship
IDEALLY, GOOD MEDICAL PRACTICES ARE REPLACED BY BET-ter ones, based on robust
comparative trials in which new interventions outperform older ones and establish new …
comparative trials in which new interventions outperform older ones and establish new …
[HTML][HTML] Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices
V Prasad, JPA Ioannidis - Implementation Science, 2014 - Springer
Abandoning ineffective medical practices and mitigating the risks of untested practices are
important for improving patient health and containing healthcare costs. Historically, this …
important for improving patient health and containing healthcare costs. Historically, this …
Why cancer screening has never been shown to “save lives”—and what we can do about it
… Vinay Prasad and colleagues argue that reductions in overall mortality should be the
benchmark and call for higher standards of evidence for cancer screening Vinay Prasad …
benchmark and call for higher standards of evidence for cancer screening Vinay Prasad …
Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology
Importance To date, the benefit of genome-driven cancer therapy has not been quantified.
Objective We sought to estimate the annual percentage of patients in the United States with …
Objective We sought to estimate the annual percentage of patients in the United States with …
Research and development spending to bring a single cancer drug to market and revenues after approval
V Prasad, S Mailankody - JAMA internal medicine, 2017 - jamanetwork.com
Importance A common justification for high cancer drug prices is the sizable research and
development (R&D) outlay necessary to bring a drug to the US market. A recent estimate of …
development (R&D) outlay necessary to bring a drug to the US market. A recent estimate of …